March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 28, 2025

Pregnancy Diet Influences Child Development Outcomes

Maternal dietary patterns during pregnancy significantly influenced neurodevelopmental disorders, with findings indicating a strong association with ADHD and autism diagnoses.

Conexiant

March 27, 2025

Medical Oddities: Metabolism’s Secret Sugar-Burning Switch

Science served weird this week: sleepy seniors, sneaky genes, and memory-hacking babies.

Conexiant

March 24, 2025

Longer Breastfeeding Duration Linked to Fewer Developmental Delays in Large Study

Children breastfed for 6+ months showed 27% lower odds of developmental delays and neurodevelopmental conditions in comprehensive Israeli analysis of 570,000+ children, with sibling comparisons confirming protective effects.

Conexiant

March 20, 2025

FDA Youth E-Cigarette Ad Linked to Lower Initiation

E-cigarette initiation among U.S. youth was reduced following The Real Cost Youth E-cigarette Prevention Campaign.

Conexiant

March 19, 2025

Medical Oddities: Brain Implants Bugged by Bacteria

Bacteria in the brain, words for longevity, and a fishy fix for kindness—this week in medical oddities.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 13, 2025

Sedentary Time and Anxiety: Walking’s Role in Risk Reduction

Researchers identified a J-shaped dose–response relationship, with minimal anxiety risk at six sedentary hours per day but a steep increase beyond this threshold, while walking for more than ten minutes on most days mitigated this effect.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters